Mark Adams

Mark Adams is an experienced professional in the pharmaceutical industry, currently serving as the Regional Account Director for Biosimilars at Organon since January 2023. In this role, Mark leads B2B customer engagement with large integrated delivery networks and federal accounts while managing a team of Biosimilar Account Specialists and Field Reimbursement Managers. Prior to joining Organon, Mark held various positions including Specialty Account Manager at Horizon Therapeutics, Regional Key Account Manager at Takeda, and several roles at Novo Nordisk and Sanofi. Mark's extensive career began at McNeil Consumer Healthcare as a Senior Sales Representative. Mark holds a Bachelor of Science degree in Kinesiology and Exercise Science from the University of Iowa and Kansas State University.